We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Etirinotecan Pegol (NKTR-102) in NSCLC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01773109
Recruitment Status : Active, not recruiting
First Posted : January 23, 2013
Last Update Posted : July 20, 2016
Information provided by (Responsible Party):
Abramson Cancer Center of the University of Pennsylvania

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Primary Completion Date : January 2016
  Study Completion Date : No date given